Ironwood Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 23.04 M | $102.06 M | 0.51% | 14.42% |
VANGUARD GROUP INC | 02/11/2025 | 19.54 M | $86.56 M | -11.34% | 12.23% |
SARISSA CAPITAL MANAGEMENT LP | 02/14/2025 | 16.39 M | $72.61 M | 0.00% | 10.26% |
PACER ADVISORS, INC. | 01/22/2025 | 11.73 M | $51.97 M | 4.00% | 7.35% |
UBS GROUP AG | 02/14/2025 | 11.20 M | $49.62 M | 0.00% | 7.01% |
ARMISTICE CAPITAL, LLC | 02/14/2025 | 9.47 M | $41.94 M | 15.46% | 5.93% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 9.07 M | $40.16 M | 5.46% | 5.68% |
BRAIDWELL LP | 02/14/2025 | 5.44 M | $24.10 M | 22.58% | 3.41% |
KYNAM CAPITAL MANAGEMENT, LP | 02/14/2025 | 4.69 M | $20.76 M | 27.13% | 2.93% |
LSV ASSET MANAGEMENT | 02/13/2025 | 4.08 M | $18.08 M | -19.20% | 2.56% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 3.31 M | $14.65 M | 0.40% | 2.07% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 2.18 M | $9.66 M | 135.50% | 1.37% |
UBS GROUP AG | 02/14/2025 | 2.18 M | $9.65 M | 130.15% | 1.36% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.98 M | $8.79 M | 4.15% | 1.24% |
DEUTSCHE BANK AG\ | 02/14/2025 | 1.57 M | $6.94 M | 47.44% | 0.98% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 1.23 M | $5.47 M | -2.10% | 0.77% |
JUPITER ASSET MANAGEMENT LTD | 02/10/2025 | 1.22 M | $5.42 M | -15.55% | 0.77% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 1.15 M | $5.10 M | 100.00% | 0.72% |
JPMORGAN CHASE & CO | 02/12/2025 | 1.07 M | $4.76 M | 250.16% | 0.67% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 1.01 M | $4.49 M | 29.02% | 0.64% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 978,135 | $4.33 M | 7.16% | 0.61% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 915,272 | $4.05 M | -25.17% | 0.57% |
SIO CAPITAL MANAGEMENT, LLC | 02/14/2025 | 907,783 | $4.02 M | 100.00% | 0.57% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 863,428 | $3.82 M | -3.09% | 0.54% |
SATURN V CAPITAL MANAGEMENT LLC | 02/14/2025 | 814,533 | $3.61 M | -27.30% | 0.51% |
PRINCIPAL FINANCIAL GROUP INC | 01/31/2025 | 765,356 | $3.39 M | 4.03% | 0.48% |
ROYCE & ASSOCIATES LP | 02/10/2025 | 735,436 | $3.26 M | 10.94% | 0.46% |
STONEPINE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 648,785 | $2.87 M | -35.12% | 0.41% |
WALLEYE CAPITAL LLC | 02/13/2025 | 580,097 | $2.57 M | 106.96% | 0.36% |
AMERIPRISE FINANCIAL INC | 02/14/2025 | 565,618 | $2.51 M | -5.45% | 0.35% |
INVESCO LTD. | 02/13/2025 | 521,988 | $2.31 M | -1.08% | 0.33% |
STATE OF WISCONSIN INVESTMENT BOARD | 02/14/2025 | 476,619 | $2.11 M | -16.88% | 0.30% |
02/28/2025 | 426,138 | $1.89 M | 100.00% | 0.27% | |
LEGAL & GENERAL GROUP PLC | 02/13/2025 | 420,686 | $1.86 M | 0.29% | 0.26% |
RUSSELL INVESTMENTS GROUP, LTD. | 02/13/2025 | 420,451 | $1.86 M | -9.20% | 0.26% |
JANE STREET GROUP, LLC | 02/14/2025 | 417,642 | $1.85 M | 29.05% | 0.26% |
PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2025 | 408,535 | $1.81 M | -10.31% | 0.26% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 405,354 | $1.80 M | 0.00% | 0.25% |
AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 396,986 | $1.76 M | -29.63% | 0.25% |
ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. | 01/23/2025 | 380,960 | $1.69 M | 0.00% | 0.24% |
FEDERATED HERMES, INC. | 02/13/2025 | 370,476 | $1.64 M | 100.00% | 0.23% |
BARCLAYS PLC | 02/13/2025 | 369,276 | $1.64 M | -11.30% | 0.23% |
MAN GROUP PLC | 02/14/2025 | 354,824 | $1.57 M | -60.34% | 0.22% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 02/14/2025 | 352,106 | $1.56 M | 18.04% | 0.22% |
RHUMBLINE ADVISERS | 01/30/2025 | 348,006 | $1.54 M | 2.97% | 0.22% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 341,455 | $1.51 M | 170.38% | 0.21% |
LOS ANGELES CAPITAL MANAGEMENT LLC | 02/04/2025 | 331,700 | $1.47 M | 2,625.11% | 0.21% |
FRANKLIN RESOURCES INC | 02/12/2025 | 309,236 | $1.37 M | -1.22% | 0.19% |
FMR LLC | 02/13/2025 | 303,273 | $1.34 M | 78.73% | 0.19% |
CITIGROUP INC | 02/12/2025 | 295,961 | $1.31 M | 58.97% | 0.19% |
Ironwood Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 327 institutional investors and hedge funds held shares of Ironwood Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 23.04 M
VANGUARD GROUP INC: 19.54 M
Sarissa Capital Management LP: 16.39 M
Pacer Advisors, Inc.: 11.73 M
ARMISTICE CAPITAL, LLC: 9.47 M
RENAISSANCE TECHNOLOGIES LLC: 9.07 M
102.77% of Ironwood Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 205.05 M shares in the last 24 months. This purchase volume represents approximately $922.74 M in transactions.